get daily headlines subscribe now! today's private briefing

Catalyst Pharmaceuticals Partners Inc. (Nasdaq: CPRX)


Last Updated: Feb-05-2016 19:32:32

CPRX News & Stock Updates

Premium Research

Catalyst Pharmaceutical Partners (NASDAQ: CPRX) Profile

CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for Brookhaven's patent portfolio in the US relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending worldwide. The Company's initial product candidate based on vigabatrin is CPP-109. CPP-109 has been granted `Fast Track` status by the U.S. Food & Drug Administration for the treatment of cocaine addiction. This indicates that the FDA has recognized that CPP-109 is intended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs.
Symbol Company Market cap
TKPYY Takeda Pharma $38.23 B
SHPG Shire Plc American Depositary Shares $32.26 B
ALPMY Astellas Pharma Inc $31.31 B
ZTS Zoetis Inc. Class A Common Stoc $20.68 B
PCYC Pharmacyclics Inc $19.73 B
SLXP Salix Pharmaceuticals $11.1 B
GRFS Grifols S.A. $10.16 B
CBST Cubist Pharmaceuticals $7.79 B
JAZZ Jazz Pharmaceuticals $7.68 B
RCPT Receptos Inc $7.33 B

CPRX Earnings

1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3rd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio 0
EPS Growth 24.75%
Recent Earnings $
Annual EPS $-0.18
Market Capitalization $0.16 B
Insider Shareholder % 0.087%
Annual Revenue $0 B
Number of Shares Outstanding 82,820 Shares
Institutional Shareholder % 54%
Annual Net Income $0B
TTM Net Profit Margin $100.14
One Year Return -47.02%
Three Year Return 37.8%
Five Year Return 53.45%
Five Year Revenue Growth 0%
Five Year Earnings Growth -52.08%
Five Year Dividend Growth 0%
Last Quarter EPS $
Annual EPS $-0.18
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 24.75%
PE Ratio
Recent Earnings $
Dividends per Share $
Stock Split Ratio
beta 0.9

CPRX Key Stats

Last Price $1.78
Net Change $-0.12 (-6.32%)
Bid $0.18
Ask Price $2.04
Open Price $1.9
Previous Close Price $1.9
High Price $1.93
Low Price $1.78
Number of Trades 993
Volume 372,800
Fifty Two Week High $5.8 (2015-07-23)
Fifty Two Week Low $1.75 (2016-02-03)
Average Daily Volume 556,871
Share Outstanding 82,820 Shares
Total Dividend Payout $0/yr
Dividend Yield 0%